Nevisense’s EIS Technology Improves Correct Biopsy Choice for Melanomas, Other Lesions
Nevisense improves the rate of correct biopsy choice even after dermoscopy, according to a study conducted in Germany. Nevisense uses electrical impedance spectroscopy (EIS), a noninvasive technology that sends a painless, very low voltage electrical current through a pigmented lesion to determine if it is benign or malignant. The article appears in SKIN – The […]